Weiss Multi Strategy Advisers LLC Albireo Pharma, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $5,799 - $7,657	322 Added 0.92%	35,322 $763,000
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $571,200 - $922,950	35,000 New	35,000 $678,000
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $214,526 - $302,344	-8,961 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $3,220 - $4,756	-152 Reduced 1.67%	8,961 $209,000
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $133,161 - $175,114	-4,867 Reduced 34.81%	9,113 $284,000

Q2 2021 Aug 16, 2021	BUY	$28.9 - $36.87 $14,421 - $18,398	499 Added 3.7%	13,980 $492,000
Q1 2021 May 14, 2021	SELL	$32.03 - $42.85 $17,648 - $23,610	-551 Reduced 3.93%	13,481 $475,000
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $30,550 - $40,810	-968 Reduced 6.45%	14,032 $526,000
Q3 2020 Nov 16, 2020	SELL	$23.19 - $41.61 $579,750 - $1.04 Million	-25,000 Reduced 62.5%	15,000 $501,000
Q2 2020 Aug 14, 2020	SELL	$14.82 - $29.92 $49,454 - $99,843	-3,337 Reduced 7.7%	40,000 $1.06 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $27.23 $73,952 - $172,556	6,337 Added 17.13%	43,337 $709,000
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $33,840 - $57,920	2,000 Added 5.71%	37,000 $941,000
Q2 2019 Aug 14, 2019	SELL	$30.67 - $37.86 $766,750 - $946,500	-25,000 Reduced 41.67%	35,000 $1.13 Million
Q4 2018 Feb 14, 2019	BUY	$20.9 - $32.57 $105,900 - $165,032	5,067 Added 9.22%	60,000 $1.47 Million
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $1,962 - $2,470	-67 Reduced 0.12%	54,933 $1.81 Million
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $578,000 - $746,200	20,000 Added 57.14%	55,000 $1.95 Million
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $937,300 - $1.38 Million	35,000 New	35,000 $1.14 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account